We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $168M
1-Year Est. Return 60.36%
This Fund
S&P 500
This Quarter Est. Return
-12.56%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$212M
AUM Growth
-$64.6M
Cap. Flow
-$15M
Cap. Flow %
-7.08%
Top 10 Hldgs %
72.97%
Holding
103
New
14
Increased
10
Reduced
14
Closed
19

Top Buys

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$2M
2
MYGN icon
Myriad Genetics
MYGN
+$1.92M
3
COGT icon
Cogent Biosciences
COGT
+$1.67M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.38M
5
TECX
Tectonic Therapeutic
TECX
+$1.3M

Top Sells

Rank Stock Value
1
CLMT icon
Calumet Specialty Products
CLMT
+$5.56M
2
VRNA
Verona Pharma
VRNA
+$4.26M
3
ICLO icon
Invesco AAA CLO Floating Rate Note ETF
ICLO
+$3.36M
4
JAAA icon
Janus Henderson AAA CLO ETF
JAAA
+$1.96M
5
VKTX icon
Viking Therapeutics
VKTX
+$1.57M

Sector Composition

Rank Sector Weight
1 Healthcare 33.25%
2 Materials 20.41%
3 Financials 19.12%
4 Communication Services 8.29%
5 Industrials 1.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARCH
101
DELISTED
Arch Resources, Inc.
ARCH
– –
-1,110
Closed -$28.9K
1 2 3 4
5

Similar funds

DI
Disciplined Investors Waco, Texas $168M AUM 23.6% 1-Year Est. Return
WFS
Widmann Financial Services Bowie, Maryland $168M AUM 24.36% 1-Year Est. Return
CCG
Catalina Capital Group Torrance, California $168M AUM 16.69% 1-Year Est. Return
7CM
7G Capital Management New York $168M AUM 45.68% 1-Year Est. Return
MAG
Meadowbrook Advisors Group Bedminster, New Jersey $168M AUM
PFA
Presper Financial Architects Akron, Ohio $168M AUM 12.94% 1-Year Est. Return
CW
Code Waechter Tampa, Florida $168M AUM 15.56% 1-Year Est. Return
IWA
Integrity Wealth Advisors Ventura, California $168M AUM 18.33% 1-Year Est. Return

David M. Knott Jr's Q1 2025 Portfolio in Review

As of Q1 2025, David M. Knott Jr held 103 positions worth $212M, down 23% from $277M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

David M. Knott Jr withdrew a net $15M in Q1 2025, closing 19 positions and reducing 14 holdings. Its most notable exit was Viking Therapeutics, an estimated $1.57M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 26% a quarter earlier, followed by Materials and Financials.

Against the trend, David M. Knott Jr opened a new position in Ultragenyx Pharmaceutical worth $1.74M.

  • David M. Knott Jr's largest Q1 2025 buy was Ultragenyx Pharmaceutical: 48,000 shares worth $1.74M.
  • David M. Knott Jr added most to Protagonist Therapeutics in Q1 2025, an estimated $990K increase.
  • David M. Knott Jr's biggest Q1 2025 reduction was Calumet Specialty Products, cutting an estimated $5.56M.
  • David M. Knott Jr fully exited Viking Therapeutics in Q1 2025, selling an estimated $1.57M.
  • David M. Knott Jr's ten largest holdings make up 73% of its $212M portfolio in Q1 2025.
  • David M. Knott Jr opened 14 new positions and closed 19 in Q1 2025.
  • David M. Knott Jr's portfolio value fell 23% quarter-over-quarter to $212M.

Based on David M. Knott Jr's 13F filing for Q1 2025, filed 12 May 2025.